SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Visteon Corp. – ‘10-K’ for 12/31/20 – ‘EX-4.2’

On:  Thursday, 2/18/21, at 7:14am ET   ·   For:  12/31/20   ·   Accession #:  1111335-21-6   ·   File #:  1-15827

Previous ‘10-K’:  ‘10-K’ on 2/20/20 for 12/31/19   ·   Next:  ‘10-K’ on 2/17/22 for 12/31/21   ·   Latest:  ‘10-K’ on 2/20/24 for 12/31/23   ·   21 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/18/21  Visteon Corp.                     10-K       12/31/20  145:17M

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.74M 
 2: EX-4.2      Instrument Defining the Rights of Security Holders  HTML     62K 
 5: EX-10.3.1   Material Contract                                   HTML    108K 
 6: EX-10.3.2   Material Contract                                   HTML    132K 
 7: EX-10.3.3   Material Contract                                   HTML    125K 
 3: EX-10.4     Material Contract                                   HTML     53K 
 4: EX-10.8     Material Contract                                   HTML     86K 
 8: EX-10.9.1   Material Contract                                   HTML     36K 
 9: EX-21.1     Subsidiaries List                                   HTML     53K 
10: EX-23.1     Consent of Expert or Counsel                        HTML     36K 
11: EX-24.1     Power of Attorney                                   HTML     44K 
12: EX-31.1     Certification -- §302 - SOA'02                      HTML     40K 
13: EX-31.2     Certification -- §302 - SOA'02                      HTML     39K 
14: EX-32.1     Certification -- §906 - SOA'02                      HTML     36K 
15: EX-32.2     Certification -- §906 - SOA'02                      HTML     36K 
22: R1          Cover                                               HTML    101K 
23: R2          Consolidated Statements of Operations               HTML    113K 
24: R3          Consolidated Statements of Comprehensive Income     HTML     67K 
                (Loss)                                                           
25: R4          Consolidated Statements of Comprehensive Income     HTML     41K 
                (Loss) (Parenthetical)                                           
26: R5          Consolidated Balance Sheets                         HTML    121K 
27: R6          Consolidated Balance Sheets (Parenthetical)         HTML     51K 
28: R7          Consolidated Statements of Cash Flows               HTML    122K 
29: R8          Consolidated Statements of Changes in Equity        HTML     79K 
30: R9          Summary of Significant Accounting Policies          HTML     89K 
31: R10         Discontinued Operations                             HTML     54K 
32: R11         Non-Consolidated Affiliates                         HTML     62K 
33: R12         Restructuring Activities                            HTML     56K 
34: R13         Inventories                                         HTML     44K 
35: R14         Other Assets                                        HTML     59K 
36: R15         Property and Equipment                              HTML     58K 
37: R16         Intangible Assets                                   HTML     66K 
38: R17         Leases                                              HTML     56K 
39: R18         Other Liabilities                                   HTML     59K 
40: R19         Debt                                                HTML     54K 
41: R20         Employee Benefit Plans                              HTML    201K 
42: R21         Stock-Based Compensation                            HTML    144K 
43: R22         Income Taxes                                        HTML    134K 
44: R23         Stockholders' Equity and Non-controlling Interests  HTML     80K 
45: R24         Earnings Per Share                                  HTML     64K 
46: R25         Fair Value Measurements                             HTML    176K 
47: R26         Financial Instruments                               HTML     88K 
48: R27         Commitments and Contingencies                       HTML     58K 
49: R28         Segment Information and Revenue Recognition         HTML    120K 
50: R29         Other Income, Net                                   HTML     50K 
51: R30         Schedule Ii - Valuation and Qualifying Accounts     HTML     61K 
52: R31         Summary of Significant Accounting Policies          HTML    140K 
                (Policies)                                                       
53: R32         Summary of Significant Accounting Policies          HTML     49K 
                (Tables)                                                         
54: R33         Discontinued Operations (Tables)                    HTML     55K 
55: R34         Non-Consolidated Affiliates (Tables)                HTML     60K 
56: R35         Restructuring Activities (Tables)                   HTML     49K 
57: R36         Inventories (Tables)                                HTML     45K 
58: R37         Other Assets (Tables)                               HTML     59K 
59: R38         Property and Equipment (Tables)                     HTML     59K 
60: R39         Intangible Assets (Tables)                          HTML     65K 
61: R40         Leases (Tables)                                     HTML     57K 
62: R41         Other Liabilities (Tables)                          HTML     61K 
63: R42         Debt (Tables)                                       HTML     46K 
64: R43         Employee Retirement Benefits (Tables)               HTML    207K 
65: R44         Stock-Based Compensation (Tables)                   HTML    142K 
66: R45         Income Taxes (Tables)                               HTML    123K 
67: R46         Stock-holders' Equity and Non-controlling           HTML     77K 
                Interests (Tables)                                               
68: R47         Earnings Per Share (Tables)                         HTML     64K 
69: R48         Fair Value Measurements (Tables)                    HTML    161K 
70: R49         Financial Instruments (Tables)                      HTML     78K 
71: R50         Commitments and Contingencies (Tables)              HTML     47K 
72: R51         Segment Information and Revenue Recognition         HTML    119K 
                (Tables)                                                         
73: R52         Other Income, Net (Tables)                          HTML     48K 
74: R53         Summary of Significant Accounting Policies -        HTML     82K 
                Narrative (Details)                                              
75: R54         Summary of Significant Accounting Policies -        HTML     48K 
                Allowance for Doubtful Accounts Receivable                       
                (Details)                                                        
76: R55         Summary of Significant Accounting Policies -        HTML     40K 
                Revenue (Details)                                                
77: R56         Discontinued Operations - Narrative (Details)       HTML     54K 
78: R57         Discontinued Operations - Schedule of discontinued  HTML     72K 
                operation (Details)                                              
79: R58         Non-Consolidated Affiliates - Narrative (Details)   HTML     50K 
80: R59         Non-Consolidated Affiliates - Investments in        HTML     43K 
                Non-Consolidated Equity Method Affiliates                        
                (Details)                                                        
81: R60         Non-Consolidated Affiliates - Summary of            HTML     40K 
                Transactions with Affiliates (Details)                           
82: R61         Non-Consolidated Affiliates - Summary of            HTML     52K 
                Investments in YFVIC (Details)                                   
83: R62         Restructuring Activities - Narrative (Details)      HTML     77K 
84: R63         Restructuring Activities - Summary of               HTML     52K 
                Restructuring Reserves and Related Activities                    
                (Details)                                                        
85: R64         Inventories (Details)                               HTML     44K 
86: R65         Other Assets - Current Assets (Details)             HTML     53K 
87: R66         Other Assets - Narrative (Details)                  HTML     48K 
88: R67         Other Assets - Noncurrent Assets (Details)          HTML     50K 
89: R68         Property and Equipment - Summary of Property and    HTML     53K 
                Equipment (Details)                                              
90: R69         Property and Equipment - Summary of Depreciation    HTML     42K 
                and Amortization (Details)                                       
91: R70         Property and Equipment - Narrative (Details)        HTML     59K 
92: R71         Intangible Assets - Schedule of Intangible Assets   HTML     70K 
                (Details)                                                        
93: R72         Intangible Assets - Narrative (Details)             HTML     53K 
94: R73         Leases - Narrative (Details)                        HTML     40K 
95: R74         Leases - Lease Costs (Details)                      HTML     49K 
96: R75         Leases - Future Minimum Lease Payments (Details)    HTML     54K 
97: R76         Other Liabilities - Other Current Liabilities       HTML     57K 
                (Details)                                                        
98: R77         Other Liabilities - Other Noncurrent Liabilities    HTML     54K 
                (Details)                                                        
99: R78         Debt - Schedule of Debt (Details)                   HTML     48K 
100: R79         Debt - Narrative (Details)                          HTML     72K  
101: R80         Employee Benefit Plans - Benefit Expenses           HTML     73K  
                (Details)                                                        
102: R81         Employee Benefit Plans - Narrative (Details)        HTML     75K  
103: R82         Employee Benefit Plans - Other Postretirement       HTML     57K  
                Employee Benefit Plans (Details)                                 
104: R83         Employee Benefit Plans - Change in Benefit          HTML    118K  
                Obligation (Details)                                             
105: R84         Employee Benefit Plans - Accumulated Other          HTML     61K  
                Comprehensive Income (Details)                                   
106: R85         Employee Benefit Plans - Future Benefit Payments    HTML     54K  
                (Details)                                                        
107: R86         Employee Benefit Plans - Asset Allocation           HTML     65K  
                (Details)                                                        
108: R87         Stock-Based Compensation - Narrative (Details)      HTML     44K  
109: R88         Stock-Based Compensation - Compensation Expense     HTML     49K  
                (Details)                                                        
110: R89         Stock-Based Compensation - Performance Based Share  HTML     57K  
                Units Narrative (Details)                                        
111: R90         Stock-Based Compensation - Performance Based Share  HTML     69K  
                Units (Details)                                                  
112: R91         Stock-Based Compensation - RSUs Narrative           HTML     70K  
                (Details)                                                        
113: R92         Stock-Based Compensation - RSUs (Details)           HTML     61K  
114: R93         Stock-Based Compensation - Stock Options and SARs   HTML     62K  
                Narrative (Details)                                              
115: R94         Stock-Based Compensation - Stock Options and SARs   HTML    138K  
                (Details)                                                        
116: R95         Income Taxes - Income Tax Provision from            HTML     54K  
                Continuing Operations (Details)                                  
117: R96         Income Taxes - Income Tax Reconciliation (Details)  HTML     70K  
118: R97         Income Taxes - Income Tax Provision Narrative       HTML     73K  
                (Details)                                                        
119: R98         Income Taxes - Deferred Tax Assets And Liabilities  HTML     71K  
                Narrative (Details)                                              
120: R99         Income Taxes - Deferred Income Tax Assets and       HTML     90K  
                Liabilities (Details)                                            
121: R100        Income Taxes - Unrecognized Tax Benefits Narrative  HTML     63K  
                (Details)                                                        
122: R101        Income Taxes - Reconciliation of Unrecognized Tax   HTML     45K  
                Benefits (Details)                                               
123: R102        Stockholders' Equity and Non-controlling Interests  HTML     70K  
                - Narrative (Details)                                            
124: R103        Stockholders' Equity and Non-controlling Interests  HTML     47K  
                - Schedule of Non-controlling Interests (Details)                
125: R104        Stockholders' Equity and Non-controlling Interests  HTML     69K  
                - AOCI (Details)                                                 
126: R105        Earnings Per Share - Basic and Diluted Earnings     HTML     88K  
                Per Share (Details)                                              
127: R106        Fair Value Measurements - Narrative (Details)       HTML     40K  
128: R107        Fair Value Measurements - Fair Value Hierarchy      HTML     65K  
                (Details)                                                        
129: R108        Fair Value Measurements - Fair Values of            HTML    174K  
                Retirement Plan Assets and Liabilities (Details)                 
130: R109        Financial Instruments - Narrative (Details)         HTML     61K  
131: R110        Financial Instruments - Derivatives Income          HTML     63K  
                Statement Location (Details)                                     
132: R111        Financial Instruments - Credit Risk (Details)       HTML     53K  
133: R112        Commitments and Contingencies - Narrative           HTML     70K  
                (Details)                                                        
134: R113        Commitments and Contingencies - Reconciliation of   HTML     47K  
                Changes (Details)                                                
135: R114        Segment Information and Revenue Recognition -       HTML     43K  
                Narrative (Details)                                              
136: R115        Segment Information and Revenue Recognition -       HTML     63K  
                Adjusted EBITDA (Details)                                        
137: R116        Segment Information and Revenue Recognition -       HTML     82K  
                Sales and Assets by Geographic Region (Details)                  
138: R117        Segment Information and Revenue Recognition -       HTML     54K  
                Revenue from external customers by products and                  
                services (Details)                                               
139: R118        Other Income, Net - Schedule of Other Income, Net   HTML     45K  
                (Details)                                                        
140: R119        Other Income, Net (Details)                         HTML     46K  
141: R120        Schedule Ii - Valuation and Qualifying Accounts     HTML     57K  
                (Details)                                                        
143: XML         IDEA XML File -- Filing Summary                      XML    257K  
21: XML         XBRL Instance -- vc-20201231_htm                     XML   5.08M 
142: EXCEL       IDEA Workbook of Financial Reports                  XLSX    182K  
17: EX-101.CAL  XBRL Calculations -- vc-20201231_cal                 XML    388K 
18: EX-101.DEF  XBRL Definitions -- vc-20201231_def                  XML   1.28M 
19: EX-101.LAB  XBRL Labels -- vc-20201231_lab                       XML   2.88M 
20: EX-101.PRE  XBRL Presentations -- vc-20201231_pre                XML   1.84M 
16: EX-101.SCH  XBRL Schema -- vc-20201231                           XSD    286K 
144: JSON        XBRL Instance as JSON Data -- MetaLinks              615±   933K  
145: ZIP         XBRL Zipped Folder -- 0001111335-21-000006-xbrl      Zip    804K  


‘EX-4.2’   —   Instrument Defining the Rights of Security Holders


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  
Exhibit 4.2
Description of Visteon Corporation Securities
Registered Under Section 12 of the Exchange Act of 1934

 
The following summary of the terms of our securities is not meant to be complete and is qualified in its entirety by reference to our second amended and restated certificate of incorporation and our third amended and restated bylaws, both of which are filed as exhibits to this Annual Report on Form 10-K, and the provisions of applicable law.

 
Authorized Capital Stock
 
Visteon has the authority to issue a total of 300,000,000 shares of capital stock, consisting of:
 
 • 250,000,000 shares of common stock, par value $0.01 per share; and
 
 • 50,000,000 shares of preferred stock, par value $0.01 per share.
 

Common Stock
 
The rights, preferences and privileges of holders of our common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of our preferred stock which we may designate and issue in the future.
 
Dividend Rights.  Subject to limitations under Delaware law, preferences that may apply to any outstanding shares of preferred stock, and contractual restrictions, holders of our common stock are entitled to receive ratably dividends or other distributions when and if declared by the board of directors. In addition to such restrictions, whether any future dividends are paid will depend on decisions that will be made by the board of directors and will depend on then existing conditions, including our financial condition, contractual restrictions, corporate law restrictions, capital requirements and business prospects. The ability of the board of directors to declare dividends also will be subject to the rights of any holders of outstanding shares of our preferred stock and the availability of sufficient funds under the Delaware General Corporation Law (“DGCL”) to pay dividends.
 
Liquidation Rights.  In the event of any liquidation, dissolution or winding up of Visteon, the holders of our common stock will be entitled to share in the net assets of Visteon available after the payment of all debts and other liabilities and subject to the prior rights of any outstanding class of our preferred stock.
 
Preemptive Rights.  Pursuant to our second amended and restated certificate of incorporation, the holders of our common stock have no preemptive rights.
 
Conversion Rights.  Shares of our common stock are not convertible.
 
Voting Rights.  Subject to the rights of the holders of any series of our preferred stock, each outstanding share of our common stock is entitled to one vote on all matters submitted to a vote of stockholders. The holders of our common stock will not have cumulative voting rights.
 

 
 

Preferred Stock
 
Under the terms of our second amended and restated certificate of incorporation, the board of directors is authorized to issue from time to time up to an aggregate of 50,000,000 shares of preferred stock and to fix or alter the designations, preferences, rights and any qualifications, limitations or restrictions of the shares of each series, including the dividend rights, dividend rates, conversion rights, voting rights, rights and terms of redemption (including sinking fund provisions), redemption price or prices, liquidation preferences and the number of shares constituting any series. These additional shares may be used for a variety of corporate purposes, including future public offerings, to raise additional capital or to facilitate acquisitions. If the board of directors decides to issue shares of preferred stock to persons supportive of current management, this could render it more difficult or discourage an attempt to


Exhibit 4.2
obtain control of Visteon by means of a merger, tender offer, proxy contest or otherwise. Authorized but unissued shares of preferred stock also could be used to dilute the stock ownership of persons seeking to obtain control of Visteon. To the extent required by 11 U.S.C. § 1123(a)(6), Visteon is prohibited from issuing shares of nonvoting equity securities (within the meaning of such statute).
 

Certain Anti-Takeover Effects of our Certificate of Incorporation, our Bylaws and Delaware Law
 
Provisions of Delaware Law.  Visteon is a Delaware corporation subject to Section 203 of the DGCL. Section 203 provides that, subject to certain exceptions specified in the law, a Delaware corporation shall not engage in certain “business combinations” with any “interested stockholder” for a three-year period after the date of the transaction in which the person became an interested stockholder unless:
 
 • prior to such time, the board of directors of the corporation approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder;
 
 • upon consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding certain shares; or
 
 • 
at or subsequent to that time, the business combination is approved by the board of directors of the corporation and authorized by the affirmative vote of holders of at least 662/3% of the outstanding voting stock that is not owned by the interested stockholder.
 
Generally, a “business combination” includes a merger, asset or stock sale or other transaction resulting in a financial benefit to the interested stockholder. Subject to certain exceptions, an “interested stockholder” is a person who, together with that person’s affiliates and associates, owns, or within the previous three years did own, 15% or more of the voting stock of the corporation.
 
Under certain circumstances, Section 203 makes it more difficult for a person who would be an “interested stockholder” to effect various business combinations with a corporation for a three-year period. The provisions of Section 203 may encourage companies interested in acquiring Visteon to negotiate in advance with our board of directors because the stockholder approval requirement would be avoided if our board of directors approves either the business combination or the transaction that results in the stockholder becoming an interested stockholder. These provisions also may make it more difficult to accomplish transactions that stockholders may otherwise deem to be in their best interests.
Board of Directors.  Our second amended and restated certificate of incorporation and our third amended and restated bylaws provide that the number of directors shall be fixed by the board of directors from time to time. The board of directors shall consist of not less than 3 nor more than 15 members. Under our third amended and restated bylaws, at all meetings of stockholders for the election of directors at which a quorum is present, a majority of the votes cast are required to elect a director except in the event of a contested election (when the number of nominees for election as directors exceeds the number of directors to be elected at such meeting). In the event of a contested election, a plurality of the votes cast would be sufficient to elect a director. Under our second amended and restated certificate of incorporation and our third amended and restated bylaws, a vote of a majority of all then outstanding capital stock entitled to vote at an election of directors is required to remove a director with or without cause and fill the resulting vacancy, except that any director elected separately by the holders of any class or series of stock shall be subject to removal with or without cause at any time by such stockholders, who will fill the resulting vacancy. Vacancies resulting from newly created directorships by reason of an increase in the size of the board of directors shall be filled by a majority vote of the board of directors, provided a quorum is present. Further, vacancies resulting from reasons other than removal or an increase in the size of the board of directors shall be filled by a majority vote of the board of directors, even if less than a quorum. These provisions may deter a stockholder from removing incumbent directors and simultaneously gaining control of the board of directors by filling the vacancies created by this removal with its own nominees.
 


Exhibit 4.2
Advance Notice Procedures.  Our third amended and restated bylaws establish an advance notice procedure for stockholder proposals to be brought before a meeting of stockholders, including proposed nominations of persons for election to the board of directors. Stockholders at a meeting will only be able to consider proposals or nominations specified in the notice of meeting or brought before the meeting by or at the direction of the board of directors or by a stockholder who was a stockholder of record on the record date for the meeting, who is entitled to vote at the meeting and who has given our corporate secretary timely written notice, in proper form, of the stockholder’s intention to bring that business before the meeting. Although our third amended and restated bylaws will not give the board of directors the power to approve or disapprove stockholder nominations of candidates or proposals regarding other business to be conducted at a special or annual meeting, our third amended and restated bylaws may have the effect of precluding the conduct of certain business at a meeting if the proper procedures are not followed or may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect its own slate of directors or otherwise attempting to obtain control of the company.
 
Action by Written Consent; Special Meetings of Stockholders.  Our second amended and restated certificate of incorporation provides that stockholder action can be taken only at an annual or special meeting of stockholders and cannot be taken by written consent in lieu of a meeting. Our second amended and restated certificate of incorporation and our third amended and restated bylaws provide that, except as otherwise required by law, special meetings of the stockholders can only be called by our chairman of the board, our chief executive officer, pursuant to a resolution adopted by a majority of our board of directors or by our secretary following receipt of one or more demands to call a special meeting of the stockholders, in accordance with the provisions of our third amended and restated bylaws, from stockholders who hold, in the aggregate, at least twenty percent of the voting power of all shares entitled generally to on the election of directors (without reference to any terms of any preferred stock).
 
Authorized but Unissued Shares.  Our authorized but unissued shares of common stock and preferred stock will be available for future issuance without stockholder approval, subject to the rules and regulations of any applicable stock exchange or similar rules. These additional shares may be utilized for a variety of corporate purposes, including future public offerings to raise additional capital, corporate acquisitions and employee benefit plans. The existence of authorized but unissued shares of common stock and preferred stock could render more difficult or discourage an attempt to obtain control of a majority of our common stock by means of a proxy contest, tender offer, merger or otherwise.
 
Limitations on Directors’ and Officers’ Liability.  Our second amended and restated certificate of incorporation contains a provision eliminating the personal liability of our directors to Visteon or any of its stockholders for monetary damages for breach of fiduciary duty to the fullest extent permitted by applicable law. Our second amended and restated certificate of incorporation and our third amended and restated bylaws also contain provisions generally providing for indemnification and prepayment of expenses to our directors and officers to the fullest extent permitted by applicable law.
Amendment of Certificate of Incorporation and Bylaws.  Our second amended and restated certificate of incorporation expressly authorizes the board of directors to adopt, amend, alter or repeal most provisions of our third amended and restated bylaws by a majority vote. The stockholders may also adopt, amend, alter or repeal our third amended and restated bylaws. Stockholder approval is also required to amend, alter, change or repeal any provision of our second amended and restated certificate of incorporation or our third amended and restated bylaws inconsistent with any provision in our second amended and restated certificate of incorporation or our third amended and restated bylaws that requires a particular vote of stockholders in order to take the action specified in such provision.
 
Tax Benefit Preservation.  Our second amended and restated certificate of incorporation provides, subject to certain exceptions therein, that any attempted transfer of Visteon’s securities prior to the earliest of:
 


Exhibit 4.2
 • December 31, 2019,
 
 • the repeal, amendment or modification of Section 382 of the Internal Revenue Code of 1986, as amended (“Section 382”) in such a way as to render the restrictions imposed by Section 382 no longer applicable to Visteon,
 
 • the beginning of a taxable year of Visteon in which no net operating loss carryovers, capital loss carryovers, alternative minimum tax credit carryovers and foreign tax credit carryovers or any loss or deduction attributable to a net realized “built-in loss” within the meaning of Section 382 of Visteon or any of its direct or indirect subsidiaries (“Tax Benefits”) are available, and
 
 • the date on which the limitation amount imposed by Section 382 in the event of an ownership change of Visteon would not be materially less than the net operating loss carry forward or net unrealized built-in loss of Visteon (the earliest of such dates being the “Restriction Release Date”), or
 
any attempted transfer of Visteon’s securities pursuant to an agreement entered into prior to the Restriction Release Date, shall be prohibited and void ab initio insofar as it purports to transfer ownership or rights in respect of such stock to the purported transferee:
 
 • if the transferor is a person or group of persons that is identified as a “5-percent shareholder” of Visteon pursuant to Treasury Regulation § 1.382-2T(g) other than a “direct public group” as defined in such regulation (a “Five-Percent Stockholder”), or
 
 • to the extent that, as a result of such transfer, either any person or group of persons shall become a Five-Percent Stockholder or the percentage stock ownership interest in Visteon of any Five-Percent Stockholder shall be increased.
 
These restrictions could prohibit or delay the accomplishment of an ownership change with respect to Visteon by (i) discouraging any person or group from being a Five-Percent Stockholder and (ii) discouraging any existing Five-Percent Stockholder from acquiring more than a minimal number of additional shares of Visteon’s stock.
 
Business Opportunities.  In recognition that our investors and their officers, directors, agents, stockholders, members, partners, affiliates and subsidiaries may serve as our directors and/or officers and that our investors may engage in similar activities or lines of business that we do, our second amended and restated certificate of incorporation provides for the allocation of certain business opportunities between us and our investors. Specifically, none of our investors or any officer, director, agent, stockholder, member, partner or affiliate of an investor has any duty to refrain from engaging directly or indirectly in the same or similar business activities or lines of business that we do. In the event that any investor acquires knowledge of a potential transaction or matter which may be a business opportunity for itself and us, we will not have any expectancy in such business opportunity, and the investor will not have any duty to communicate or offer such business opportunity to us and may pursue or acquire such business opportunity for itself or direct such opportunity to another person. In addition, if a director or officer of us who is also an officer, director, agent, stockholder, member, partner or affiliate of any investor acquires knowledge of a potential transaction or matter which may be a business opportunity for us and an investor, we will not have any expectancy in such business opportunity unless such


Exhibit 4.2
business opportunity is expressly offered to such person solely in his or her capacity as a director or officer of us.
No such person shall be liable to Visteon or any of its subsidiaries for breach of any fiduciary or other duty, as a director or officer or otherwise, by reason of the fact that such person pursues or acquires such business opportunity, directs such business opportunity to another person or fails to present such business opportunity, or information regarding such business opportunity, to Visteon or its subsidiaries.
 
These provisions of our certificate of incorporation are permitted by Section 122 of the DGCL, and, accordingly, we and all of our stockholders will be subject to them.
 
Transactions with Interested Directors or Officers.  In recognition that we may engage in material business transactions with one or more of our directors or officers, an entity in which one or more of our directors or officers are its directors or officers or have a financial interest, our third amended and restated bylaws provide that such a contract or transaction will not be void or voidable solely because a director or officer is interested, or solely because the director or officer is present at or participates in the meeting which authorizes the contract or transaction, or solely because such person’s votes are counted for such purpose if:
 
 • the material facts as to such person’s or persons’ relations or interest as to the contract or transaction are disclosed or are known to the board of directors or the committee, and the board of directors or committee in good faith authorizes the contract or transaction by the affirmative vote of a majority of disinterested directors, even though the number of disinterested directors may be less than a quorum; or
 
 • the material facts as to such person’s or person’s relationship or interest as to the contract or transaction are disclosed or are known to the stockholders entitled to vote thereon, and the contract or transaction is specifically approved in good faith by vote of the stockholders; or
 
 • the contract or transaction is fair as to us as of the time it is authorized, approved or ratified by the board of directors, a committee thereof or the stockholders.
 

Transfer Agent and Registrar
 
Computershare Limited is the transfer agent and registrar for our common stock.
 

Listing of Our Common Stock
 
Currently, our common stock is listed on the NASDAQ stock market under the trading symbol “VC”.
 



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/18/218-K
For Period end:12/31/20SD
12/31/1910-K,  SD
 List all Filings 


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/20/24  Visteon Corp.                     10-K       12/31/23  139:14M
 2/16/23  Visteon Corp.                     10-K       12/31/22  137:16M
 2/17/22  Visteon Corp.                     10-K       12/31/21  142:16M


18 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/23/20  Visteon Corp.                     DEF 14A     6/03/20    1:5.2M                                   Broadridge Fin’l So… Inc
12/20/19  Visteon Corp.                     8-K:1,2,9  12/19/19   11:309K                                   Donnelley … Solutions/FA
 6/01/18  Visteon Corp.                     8-K:1,2,9   5/30/18    2:112K                                   Donnelley … Solutions/FA
 2/22/18  Visteon Corp.                     10-K       12/31/17  116:23M
 2/14/18  Visteon Corp.                     8-K:5,9     2/12/18    2:135K                                   Donnelley … Solutions/FA
11/17/17  Visteon Corp.                     8-K:1,2,9  11/14/17    2:93K                                    Donnelley … Solutions/FA
 4/27/17  Visteon Corp.                     10-Q        3/31/17   82:8M
 3/27/17  Visteon Corp.                     8-K:1,2,9   3/24/17    2:228K                                   Donnelley … Solutions/FA
 6/10/16  Visteon Corp.                     8-K:5,8,9   6/09/16    4:432K                                   Donnelley … Solutions/FA
 3/27/15  Visteon Corp.                     8-K:1,8,9   3/25/15    3:1.1M                                   Donnelley … Solutions/FA
 4/14/14  Visteon Corp.                     8-K:1,2,9   4/09/14    2:1M                                     Donnelley … Solutions/FA
10/31/12  Visteon Corp.                     8-K:5,9    10/29/12    6:240K                                   Donnelley … Solutions/FA
 9/18/12  Visteon Corp.                     8-K:5,9     9/13/12    5:215K                                   Donnelley … Solutions/FA
11/03/11  Visteon Corp.                     10-Q        9/30/11   37:4.3M                                   Donnelley … Solutions/FA
10/22/10  Visteon Corp.                     S-1                    7:989K                                   Donnelley … Solutions/FA
10/01/10  Visteon Corp.                     8-K:1,2,3,5 9/27/10   10:2.3M                                   Donnelley … Solutions/FA
 9/30/10  Visteon Corp.                     8-A12G                 5:582K                                   Donnelley … Solutions/FA
 9/07/10  Visteon Corp.                     8-K:1,9     8/31/10    4:1.3M                                   Donnelley … Solutions/FA
Top
Filing Submission 0001111335-21-000006   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 9:48:02.2am ET